Next Quarterly Earnings
Tuesday, April 27, 2027
Expected
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company based in Pratteln. It develops and markets treatments for rare neuromuscular diseases, including Duchenne muscular dystrophy. Its shares are listed on the SIX Swiss Exchange.
Santhera Pharmaceuticals last reported quarterly earnings on 9/30/2026 (Q2 2026). Earnings per share (EPS) came in at -1.50 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.